Relationship Between Level of Heart Type Fatty Acid Binding Protein (Before and after Procedures) with Acute Renal Failure after PCI in Patients Under PCI

Author(s):  
Habib Haybar ◽  
Ahmad R. Assareh ◽  
Mina Mohammadzadeh ◽  
Shahla A. Hovyzian

Background & Objective: Acute renal failure (AKI) is one of the most important complications of PCI. Due to delay in creatinine increase, we need specific factors to detect AKI earlier. The aim of this study is to evaluate the valuable factors by focusing on HFAB-P that can be predictive for AKI after Percutaneous Coronary Intervention (PCI). Methods: This prospective study was performed on 95 patients (55 males and 44 females aged between 49-78 years) under PCI in Golestan and Imam Khomeini hospitals in Ahvaz. Patients were divided into three groups based on the development of AKI after the procedure: no AKI, severe AKI (doubling of serum creatinine or needing dialysis) and any type of AKI (increased creatinine ≥ 0/3 mg/dl or a 50% increase in the means of 1/5 times serum creatinine). The demographic and clinical characteristics of the patients, the medical history and the results of the HFABP marker, GFR, and creatinine before and after PCI were evaluated for all patients. Results: The progenies showed 6 patients with severe AKI, 17 patients with any type of AKI, and 72 patients without AKI. Diabetes (P = 0.003), hypertension (P = 0.027), gender of patients (P = 0.025) and hospital admission days (P <0.001) were significantly different among the groups. Patients' age and positive troponin were significantly higher in patients with AKI. HFABP was the only factor that had significant changes before and after PCI (P <0.001). The cut-off value of HFABP was 4.69 with 95.6% sensitivity and 84.7% specificity. It has a good negative predictive value of 98.39% which suggests it to be a good test for the AKI prediction. Glomerular Filtration Rate (GFR) and creatinine (Cr) were significantly different after PCI (P <0.001). Conclusion: HFABP can be considered as a predictor for AKI after PCI. Moreover, our study suggests that evaluating several parameters such as Cr and GFR before and after PCI can predict the AKI development after PCI.

2007 ◽  
Vol 72 (3) ◽  
pp. 348-358 ◽  
Author(s):  
K. Negishi ◽  
E. Noiri ◽  
T. Sugaya ◽  
S. Li ◽  
J. Megyesi ◽  
...  

2021 ◽  
Vol 15 (7) ◽  
pp. 1600-1602
Author(s):  
Muhammad Asif Farooqi ◽  
Bilal Rafique Malik ◽  
Aneeqa Ilyas

Background: Percutaneous coronary intervention (PCI) is a nonsurgical technique for treating obstructive coronary artery disease. Aim: To assess the causes / factors leading to mortality after percutaneous coronary intervention Study design: Cross sectional study Setting: Department of Cardiology, Punjab institute of cardiology, Lahore. Duration: Six months i.e. from1stJuly 2020 to 31stDecember 2020. Methods: Medical records of 100 cases who dies after PCI for acute coronary syndrome were taken from record center. Medical record of patients aged 40 to 70 years, both genders underwent PCI and did not survived after PCI were included. Location of lesion, and severity of vessel disease, type of procedure and acute renal failure were considered as factors of mortality and were noted on proforma while analyzed in SPSS 20. Results: The mean age of the patients was 54.20 ± 8.84 years. There were 42(42%) males and 58(58%) females. History of smoking was positive in 48 (48%) cases, diabetes in 51(51%) and hypertension in 55(55%) cases. Among the factors, old age (≥50 years) was observed in 64(64%) patients while 36(36%) had age <50 years. There were 39(39%) patients who underwent PCI under emergency situation and 61(61%) patients had PCI under elective circumstances. Acute renal failure was noticed in 37(37%) patients. There were more patients of right coronary artery disease i.e. 54(54%) who underwent PCI. Conclusion: Out of all factors leading to mortality after PCI, older age at the time of PCI is the most common factor, followed by right coronary artery disease and multi-vessel disease. Keywords: Mortality, PCI, angiography, cardiovascular complications


Sign in / Sign up

Export Citation Format

Share Document